These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease. Greisman SG; Redecha PB; Kimberly RP; Christian CL J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531 [TBL] [Abstract][Full Text] [Related]
26. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237 [TBL] [Abstract][Full Text] [Related]
27. Antibodies against nuclear poly(A) polymerases in rheumatic autoimmune diseases. Stetler DA; Reichlin M; Berlin CM; Jacob ST J Clin Immunol; 1987 Jan; 7(1):24-8. PubMed ID: 3031126 [TBL] [Abstract][Full Text] [Related]
28. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis. Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764 [TBL] [Abstract][Full Text] [Related]
29. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders. Saxena R; Sturfelt G; Nived O; Wieslander J Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578 [TBL] [Abstract][Full Text] [Related]
30. Enhancement of Clq binding activity by IgM rheumatoid factor. Zilberfarb JL; Andrews BS; Young AC; Davis JS J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433 [TBL] [Abstract][Full Text] [Related]
31. Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. Bernstein RM; Hobbs RN; Lea DJ; Ward DJ; Hughes GR Arthritis Rheum; 1985 Mar; 28(3):285-93. PubMed ID: 3872129 [TBL] [Abstract][Full Text] [Related]
32. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA. Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806 [TBL] [Abstract][Full Text] [Related]
33. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
34. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer. Medof ME J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370 [TBL] [Abstract][Full Text] [Related]
35. A method to differentiate between anti-C1q antibodies and C1q-binding immune complexes using collagenase-digested solid phase C1q. Menzel JE; Scherak O; Kolarz G; Gamerith F; Youngchaiyud U J Immunol Methods; 1991 Apr; 138(2):165-71. PubMed ID: 1851794 [TBL] [Abstract][Full Text] [Related]
36. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays. Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566 [TBL] [Abstract][Full Text] [Related]
37. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. Abdou NI; Wall H; Lindsley HB; Halsey JF; Suzuki T J Clin Invest; 1981 May; 67(5):1297-304. PubMed ID: 6971876 [TBL] [Abstract][Full Text] [Related]
38. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements. Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403 [TBL] [Abstract][Full Text] [Related]
39. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. Cook AD; Mackay IR; Cicuttini FM; Rowley MJ J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865 [TBL] [Abstract][Full Text] [Related]
40. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA. Larsson A; Sjöquist J J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]